RFP for Addressing Knowledge Gaps in Ulcerative Colitis Care
Pfizer has issued an RFP for addressing knowledge gaps in ulcerative colitis (UC) care.
Through the RFP, grants of up to $200,000 will be awarded to enhance education for healthcare professionals (HCPs), specifically community gastroenterologists and advanced practice providers (APPs), involved in diagnosis, treatment, and management of patients with UC. Pfizer is particularly interested in programs that focus on educational needs in UC, including but not limited to, education of new oral therapies for UC, including S1P modulators mechanism of action and data; education on transition from conventional to advance therapy in UC (treat to target and shared decision making); and burden of disease and management of isolated proctitis in UC.
The following may apply: medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.
For complete program guidelines and application instructions, see the Pfizer website.
Submissions to this sponsor/donor are managed by the Office of Corporate and Foundation Relations. Please contact your unit-assigned ASUF Director of Development or Research Advancement Specialist at your earliest convenience to ensure ASU's strategic coordination and management of funding applications.